✦ LIBER ✦

Doxorubicin (A) followed by docetaxel (T) versus doxorubicin + docetaxel (AT) in the adjuvant treatment of breast cancer (BC)

✍ Scribed by A. Di Leo; J. Crown; L.M. Nogaret; K. Duffy; S. Bartholomeus; S. Dolci; S. Rowan; N. O'Higgins; A. Riva; M.J. Piccart

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Doxorubicin/Pemetrexed Followed by Docet

✍ Andreas Schneeweiss; Ilka Lauschner; Amparo Ruiz; Angel Guerrero; Pedro Sánchez- 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 88 KB

P95 Neoadjuvant Doxorubicin followed seq

✍ A. Ezzat; M. Rahal; D. Ajarim; A. Al-Sayed; A. Tulbah; O. Al-Malik; M. Al-Shaban 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Prospective phase II study of: neo-adjuv

✍ T. Al-Tweigeri; Rahal; D. Ajarim; A. Al-Sayed; A. Tulba; O. Al-Malik; M. Al-Shab 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

0178 Results of clinical endpoints of a

✍ A. Schneeweiss; A. Ruiz; P. Rovira; A. Bottini; A. Manikhas; J. Wacker; T. Schum 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Genomic predictors of response to doxoru

✍ M. Martin; A. Romero; M. C. U. Cheang; J. A. López García-Asenjo; J. A. García-S 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 296 KB

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PL

✍ S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB